Powerful Medical Receives €40 Million IPCEI Grant — read the full story

PM Magazine

Doctor holding Roche cobas® pulse point-of-care device displaying PMcardio AI-powered ECG interpretation for real-time heart attack detection at the patient bedside.

PMcardio Expands Heart Attack Detection to Patient Bedside through Roche cobas® pulse Point of Care Platform

Powerful Medical has partnered with Roche to integrate AI-powered ECG interpretation from PMcardio into the cobas® pulse point-of-care platform. Combined with Roche’s Elecsys® high-sensitivity cardiac Troponin T assay, this solution enables clinicians to rapidly and accurately rule in or rule out heart attacks directly at the patient’s bedside.

Editor's Choice

Powerful Medical awarded €40M IPCEI grant to expand AI diagnostics for heart attacks, heart failure, and arrhythmias

Powerful Medical Receives €40 Million Non-Dilutive Grant to Accelerate Early Diagnosis of Cardiovascular Diseases with AI

28. July 2025
Collage showing a conference speaker, PMcardio app UI, hospital partnerships across Europe, and a research award ceremony.

May Highlights from Powerful Medical: PMcardio 3.0 Launch, STEMI Research, and Clinical Breakthroughs

7. June 2025
Introducing PMcardio for Individuals 3.0: A New Era in AI-Powered Second Opinions for ECG Interpretation

Introducing PMcardio for Individuals 3.0: A New Era in AI-Powered Second Opinions for ECG Interpretation

19. May 2025
Doctor holding Roche cobas® pulse point-of-care device displaying PMcardio AI-powered ECG interpretation for real-time heart attack detection at the patient bedside.

PMcardio Expands Heart Attack Detection to Patient Bedside through Roche cobas® pulse Point of Care Platform

Powerful Medical has partnered with Roche to integrate AI-powered ECG interpretation from PMcardio into the cobas® pulse point-of-care platform. Combined with Roche’s Elecsys® high-sensitivity cardiac Troponin T assay, this solution enables clinicians to rapidly and accurately rule in or rule out heart attacks directly at the patient’s bedside.
Powerful Medical awarded €40M IPCEI grant to expand AI diagnostics for heart attacks, heart failure, and arrhythmias

Powerful Medical Receives €40 Million Non-Dilutive Grant to Accelerate Early Diagnosis of Cardiovascular Diseases with AI

Powerful Medical announces it has been selected to receive over €40 million in non-dilutive funding from the European Commission’s IPCEI Tech4Cure initiative. This significant grant will accelerate global adoption and clinical validation of PMcardio®, the world’s first AI-powered platform enabling rapid and accurate diagnosis of heart attacks and other life-threatening cardiac conditions, dramatically expanding the company’s potential to save millions of lives worldwide.
Image is showing logos of the two companies mentioned in the text - PMcardio and Alphaiota

Alphaiota Expands Strategic Partnership with PMcardio to Launch First AI-Powered Heart Attack Diagnostic Platform in Saudi Arabia

Alphaiota and PMcardio announce the expansion of their strategic partnership to bring the first AI-powered heart attack diagnostic solution to the Kingdom of Saudi Arabia. Developed by Powerful Medical, a medical device manufacturer specializing in AI-driven cardiovascular diagnostics, PMcardio will be introduced by Alphaiota as the exclusive distributor in the region, marking a first-of-its-kind deployment in the Middle East.
Image ilustrating the VAIA grant reception containing logos of important public institutions

Powerful Medical Awarded €1M EU-Funded Grant by Slovak Ministry of Economy to Advance AI-ECG Heart Attack Diagnostics

Powerful Medical has received over €985,000 in funding from the Slovak Ministry of Economy, as part of the EU-funded Recovery and Resilience Plan. The grant supports the continued development of our AI-based ECG interpretation technology, focused on improving early diagnosis and treatment of acute coronary syndromes (ACS).

Stay on the pulse with our newsletter

Your submission was successful